Events associated with cancer-dependent platelet activation is the release of TXA2 and PGE2 (as a minor product) and proteins from a-granules [such as TGF-β and platelet-derived growth factor (PDGF)], which contribute to tumor cell dissemination into the bloodstream [16]. The gene discussed is TGFB1; the disease is neoplasm.